An observational study in Bariatric Surgery, Bone Health and Severe Obesity, sponsored by CHU de Quebec-Universite Laval. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-10.
Sponsored by CHU de Quebec-Universite Laval · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Obesity, Morbid with a site in Canada — 7 open to participants now, 10 under way, none of them phase 3. Obesity, Morbid · Canada.
Among the 32 studies in Obesity, Morbid with a site in Canada, this one is the 4th largest by planned enrollment of the 10 observational ones that give a count, is one of 2 that started in 2022, is one of 10 observational ones, and was the 29th registered.
941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.
Browse Obesity, Morbid studies →7 of the 32 studies in Obesity, Morbid with a site in Canada are open now. Recruiting first, the newest first:
Laval University · Sites in Canada
Ages 18–65
Laval University · Sites in Canada
Ages 18–60
Nova Scotia Health Authority · Sites in Canada
Ages 18–65 · Healthy volunteers
CHU de Quebec-Universite Laval · Sites in Canada
Ages 18–60 · Healthy volunteers
Laval University · Sites in Canada
Ages 18–60
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 2 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 156 is above the median of 80 across 311 observational studies indexed under Obesity, Morbid.
Median enrollment 57 across the 22 interventional studies, 145 across the 10 observational. Of the 18 that completed or were terminated, 7 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 32 have an industry lead sponsor. The 10 most frequent:
CHU de Quebec-Universite Laval is the lead sponsor of 137 studies on the registry; 27 are open to participants now.
CHU de Quebec-Universite Laval has 2 studies filed under Obesity, Morbid — fewer than ten, so there is no comparison to draw.
3 of the studies in Obesity, Morbid with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05242835Laval UniversityManagement of Sleeve Gastrectomy Failure Using Single-anastomosis Metabolic Surgery | 2027-01 |
| NCT05120492Nova Scotia Health AuthorityOptimal Management of Extreme Obesity and Severe Knee Osteoarthritis Feasibility Trial | 2027-07 |
| NCT06002906University Health Network, TorontoThe Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery. | 2027-07-03 |
Add all 3 to your calendar (.ics) → With an account.
Among the 32 studies in Obesity, Morbid with a site in Canada, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Background: Bariatric surgery is gaining in popularity. While it's health benefits are undisputed, the older malabsorptive bariatric procedures (Roux-in-Y gastric bypass - RYGB and biliopancreatic diversion - BPD) are associated with an increased risk of fractures and falls as early as 3-5 years after surgery. Sleeve gastrectomy - SG is now the most performed bariatric procedure. Although SG does not cause malabsorption, it is predicted to result in bone and muscle loss via weight loss and weight loss-independent mechanisms. Primary aim: to compare the changes in spine volumetric bone mineral density (vBMD) by quantitative computed tomography (QCT) and muscle mass at mid-femur by computed tomography (CT) at 3 years in the 3 groups of: 1) men; 2) premenopausal women; 3) postmenopausal women after SG versus their respective non-surgical peers who did not undergo SG in the 3-year period following recruitment. Secondary aims: to compare the changes in vBMD by QCT at skeletal sites other than the spine and in areal bone mineral density (aBMD) by dual-energy X-ray absorptiometry (DXA), whole-body muscle mass by DXA, muscle quality by CT at mid-femur and muscle strength as well as in selected physical performance and capacity tests shown to predict falls and fractures between 0-1 and 1-3 years after SG in the same 3 groups after SG vs. in the respective non-surgical groups.
This is a multicentre, prospective and observational study comprising a SG bariatric group undergoing SG (n=117) comprising an equal number of men, premenopausal and postmenopausal women (n=39/group) meeting the inclusion/exclusion criteria, and assessed before, and at one and 3 years after SG. An obese non-surgical group (n=39; 13 men, premenopausal and postmenopausal women) meeting the criteria for SG but who will not undergo surgery during the 3-year period following recruitment will be assessed using the same tests and at the same timepoints.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
How quickly the kidneys clear creatinine, a waste product, from the blood. A study may estimate it from a blood test with age, weight and sex (often by the Cockcroft–Gault formula), or measure it using blood and urine collected over a set time. Given in mL/min; higher is better.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Creatinine clearance (CrCl)
How quickly the kidneys clear creatinine, a waste product, from the blood. A study may estimate it from a blood test with age, weight and sex (often by the Cockcroft–Gault formula), or measure it using blood and urine collected over a set time. Given in mL/min; higher is better.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
n = 39 men with obesity undergoing sleeve gastrectomy
Procedure: Bariatric surgery
n = 39 premenopausal women with obesity undergoing sleeve gastrectomy
Procedure: Bariatric surgery
n = 39 postmenopausal women with obesity undergoing sleeve gastrectomy
Procedure: Bariatric surgery
n = 39 (13 men, 13 premenopausal and 13 postmenopausal women) obese non-surgical individuals
Sleeve gastrectomy
Change in vBMD at the spine (L2-L3) and proximal femur
assessed by QCT
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in muscle mass at mid-femur
determined by measuring cross-sectional area at mid-femur (CT)
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in vBMD at skeletal sites other than the spine
assessed by QCT
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in aBMD at skeletal sites
assessed by DXA
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in whole body muscle mass
assessed by DXA
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in muscle quality at mid-femur
muscle fat infiltration, using CT attenuation in Hounsfield unit (HU)
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in muscle strength
assessed by CT
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in upper extremity muscle strength
by hand grip strength
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in lower extremity muscle strength
knee extensor strength
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in muscle mass (muscle cross-sectional area) and function
by timed up and go test
Time frame: before, 1 year after and 3 years after bariatric surgery
Change in muscle mass (muscle cross-sectional area) and function
by 6-minute walk test
Time frame: before, 1 year after and 3 years after bariatric surgery
The clinical impact of SG on self-reported falls
by self-reported questionnaire (yes/No)
Time frame: before, 1 year after and 3 years after bariatric surgery
The clinical impact of SG on self-reported incidence of vertebral and non-vertebral fractures
by questionnaire (yes/No and number of fractures, how)
Time frame: before, 1 year after and 3 years after bariatric surgery
The proportion of participants meeting the recommendations for physical activity
by international physical activity questionnaire short version (score in MET-min/week), (Min 495 MET-minute/week, Max 1200 MET-minute/week)
Time frame: before, 1 year after and 3 years after bariatric surgery
The proportion of participants meeting the recommendations for dietary protein intake
Dietary journal, Calculating macronutrient and micronutrient intake per day 3 web-based 24-h recalls
Time frame: before, 1 year after and 3 years after bariatric surgery
The proportion of participants meeting the recommendations for calcium and vitamin D intake from diet and supplements
serum D vitamin (25ODH) in blood sample
Time frame: before, 1 year after and 3 years after bariatric surgery
The proportion of participants meeting the recommendations for calcium and vitamin D intake from diet and supplements
Parathyroid hormone (PTH) in blood sample
Time frame: before, 1 year after and 3 years after bariatric surgery
Changes in C-Telopeptide, amino-terminal propeptide of type 1 procollagen (P1NP), osteocalcin
assessed by blood sample. unit: micro g/l
Time frame: before, 1 year after and 3 years after bariatric surgery
Changes in calcium,
assessed by blood sample. unit: mmol/l
Time frame: before, 1 year after and 3 years after bariatric surgery
Changes in albumin,
assessed by blood sample. unit:g/l
Time frame: before, 1 year after and 3 years after bariatric surgery
Changes in creatinin
assessed by blood sample. unit: micromol/l
Time frame: before, 1 year after and 3 years after bariatric surgery
Changes in folliculo-stimulant (FSH)
assessed by blood sample. unit: UI/l FSH will help categorize hysterectomized women or those with non-menopausal amenorrhea. Premenopause will be defined as menses in the last year.
Time frame: FSH will be measured at the time of surgery, when women had withdrawn their hormones for 3 months preceding surgery.
Started Sep 2022 (actual). Primary completion is estimated for Aug 2026, 47 months after the start.
Of 138 non-industry observational studies under Obesity, Morbid, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 132. This study's planned 47 months is close to that.
Counting every sponsor, half of 139 studies reached it within 46 months; a quarter within 16 and three quarters within 132.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
CHU de Quebec-Universite Laval →